CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 70 enrolled
Drug / intervention
0.5% Bupivicainedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02055053
NCT02055053Phase 4Completed
CompareCT.gov

A Randomized, Double-blinded, Placebo-controlled Trial of the Effects of Infusing Local Anesthesia on Post-operative Pain During Laparoscopic Inguinal Hernia Repair

Lahey Clinic·interventional·Posted Feb 4, 2014·Updated Jan 11, 2022

In Brief

A Phase 4 clinical trial evaluating 0.5% Bupivicaine for Post Operative Pain (Post Laparoscopic Hernia Repair). Completed, enrolled 70 participants across 1 site.

Detailed Summary

To assess effect of local anesthetic into the preperitoneal space during laparoscopic hernia repair on post-operative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Operative Pain (Post Laparoscopic Hernia Repair)
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 4, 2014
Enrollment StartAug 1, 2013
Primary CompletionOct 16, 2019
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 12.4 years ago

Interventions

0.5% Bupivicainedrug

Local anesthetic